Cargando…
Epidermal growth factor promotes cyclin G2 degradation via calpain-mediated proteolysis in gynaecological cancer cells
Cyclin G2 (CCNG2) is an atypical cyclin that functions to inhibit cell cycle progression and is often dysregulated in human cancers. We have previously shown that cyclin G2 is highly unstable and can be degraded through the ubiquitin/proteasome pathway. Furthermore, cyclin G2 contains a PEST domain,...
Autores principales: | Bernaudo, Stefanie, Khazai, Shahin, Honarparvar, Eilyad, Kopteva, Alina, Peng, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481008/ https://www.ncbi.nlm.nih.gov/pubmed/28640887 http://dx.doi.org/10.1371/journal.pone.0179906 |
Ejemplares similares
-
miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation
por: Salem, Mohamed, et al.
Publicado: (2019) -
Calpain-mediated proteolysis as driver and modulator of polyglutamine toxicity
por: Incebacak Eltemur, Rana Dilara, et al.
Publicado: (2022) -
The Growth and Tumor Suppressors NORE1A and RASSF1A Are Targets for Calpain-Mediated Proteolysis
por: Kuznetsov, Sergey, et al.
Publicado: (2008) -
Dual vulnerability of tau to calpains and caspase-3 proteolysis under neurotoxic and neurodegenerative conditions
por: Cheng Liu, Ming, et al.
Publicado: (2011) -
Calpain A modulates Toll responses by limited Cactus/IκB proteolysis
por: Fontenele, Marcio, et al.
Publicado: (2013)